| pubmed-article:21400483 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C0026848 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C1150462 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C0597177 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C1272321 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:21400483 | lifeskim:mentions | umls-concept:C1287238 | lld:lifeskim |
| pubmed-article:21400483 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:21400483 | pubmed:dateCreated | 2011-6-30 | lld:pubmed |
| pubmed-article:21400483 | pubmed:abstractText | Anti-signal recognition particle (anti-SRP) autoantibodies are associated with severe acquired necrotizing myopathies. The role of these autoantibodies remains elusive, and the evolution of anti-SRP levels over time is unknown. In this study, we developed an addressable laser bead immunoassay (ALBIA) technique to investigate a correlation between anti-SRP levels, serum creatine kinase (CK) levels, and muscle strength in patients with necrotizing myopathy. | lld:pubmed |
| pubmed-article:21400483 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21400483 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21400483 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21400483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21400483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21400483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21400483 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21400483 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21400483 | pubmed:issn | 1529-0131 | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:TronFrançoisF | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:HersonSergeS | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:AmouraZahirZ | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:GuiguetMargue... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:MarieIsabelle... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:GilbertDanièl... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:BenvenisteOli... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:BoyerOlivierO | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:DrouotLaurent... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:BehinAnthonyA | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:EymardBrunoB | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:CharuelJean-L... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:MussetLucileL | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:Bloch-Queyrat... | lld:pubmed |
| pubmed-article:21400483 | pubmed:author | pubmed-author:JouenFabienne... | lld:pubmed |
| pubmed-article:21400483 | pubmed:copyrightInfo | Copyright © 2011 by the American College of Rheumatology. | lld:pubmed |
| pubmed-article:21400483 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21400483 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:21400483 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21400483 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21400483 | pubmed:pagination | 1961-71 | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:meshHeading | pubmed-meshheading:21400483... | lld:pubmed |
| pubmed-article:21400483 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21400483 | pubmed:articleTitle | Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. | lld:pubmed |
| pubmed-article:21400483 | pubmed:affiliation | Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France. olivier.boyer@chu-rouen.fr | lld:pubmed |
| pubmed-article:21400483 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21400483 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
